OSA underdiagnosis: A world of difference, a common challenge

In this candid, cross-regional discussion, international clinical leaders challenged the status quo, questioned entrenched diagnostic norms, explored what’s failing current pathways and spotlighted scalable innovations reshaping access to care. Drawing from real-world experience across diverse health systems, this session spurred open dialogue on redefining how, where and for whom obstructive sleep apnea (OSA) is identified. Concluding with forward-looking insights, the panel examined how to dismantle persistent, systemic barriers and move beyond outdated screening tools toward a more inclusive, efficient and impactful future for the missions of people living with undiagnosed OSA globally.

This discussion:

• Critically assessed the limitation of traditional diagnostic metrics in identifying clinically meaningful OSA across different healthcare systems and geographies
• Analyzed global approaches to improving OSA detection, including task-shifting, technology-enabled models and integration with cardiometabolic and primary care
• Recognized persistent diagnostic bottlenecks across diverse systems, from workforce shortages to inequitable access to sleep testing
• Envisioned future-forward strategies for addressing the underdiagnosis crisis head-on through innovation, interdisciplinary collaboration and system redesign